Form D Explorer

Form C-AR — Genomic Expression, Inc.

0001665160-24-001421 · filed Oct 18, 2024

Offering

Target
—
Maximum
—
Security type
—
Price per security
—
Deadline
—
Oversubscription
—

Issuer

CIK
1611868
Entity
Corporation
Jurisdiction
DE
Address
100 CUMMINGS CENTER, SUITE 451C,
BEVERLY, MA 01915
Phone
—

Most recent fiscal year financials

Total assets
$1,024,831
Cash
—
Short-term debt
$288,027
Long-term debt
$472,665
Revenues
$222,724
COGS
—
Taxes paid
—
Net income
$-274,187

View the original filing on SEC EDGAR ↗